Skip to content
Search AI Powered

Latest Stories

Britain may still be wasting billions on Covid gear, spending watchdog warns

Britain may be wasting nearly £3 billion on contracts for Covid-19 gear that have not given value for money, with millions spent each month storing unneeded and sometimes out-of-date kit, a watchdog said on Wednesday (March 30).

The report by the parliament-supervised National Audit Office (NAO) will fuel opposition claims that prime minister Boris Johnson's government was wasteful and nepotistic in its allocation of huge contracts during the two-year pandemic.


But the Department of Health and Social Care (DHSC), which handles the personal protective equipment (PPE) supplies, said it had been prudent to have too much rather than too little given the emergency.

According to the NAO, the ministry had identified 3.6 billion items unsuitable for front line use, the government spent over £700 million on storage alone by November 2021, and 1.5 billion PPE items were estimated to be past expiry date.

"The Department (DHSC) is continuing to manage 176 contracts where it believes it may not achieve full value for money, with an estimated £2.7 billion at risk," said NAO chief Gareth Davies.

'VIP' SUPPLIERS

Johnson has said he is proud of what the government did to secure PPE, and the health ministry said it had delivered 19.1 billion items of PPE to keep frontline staff safe.

"Having too much PPE was preferable to having too little in the face of an unpredictable and dangerous virus," a DHSC spokesperson said.

Britain has reported over 160,000 deaths from Covid-19.

The DHSC spokesperson added that where contracts were in dispute, it was seeking to recover costs from suppliers.

The chair of the parliamentary Committee of Public Accounts, Meg Hillier, said that the public might run out of patience with ongoing costs, such as the continued £7 million a month spend on storing unneeded PPE cited by the NAO.

"Whatever forbearance the taxpayer may have had at the start of the pandemic, this will quickly wear thin if DHSC can’t now manage the consequences," she said.

NAO analysis of the policy to fast-track some contracts found that of those so-called "VIP lane" suppliers, 53 per cent provided some unsuitable PPE.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less